| 621 |
LABORATORY SCREENING FOR RHABDOMYOLYSIS AND REFERENCE LABORATORY VALUES OF MUSCULAR ACTIVITY FOR BEGINNERS PRACTICING VIGOROUS EXERCISES |
2007 |
| 622 |
LABORATORY SCREENING FOR RHABDOMYOLYSIS AND REFERENCE LABORATORY VALUES OF MUSCULAR ACTIVITY FOR BEGINNERS PRACTICING VIGOROUS EXERCISES |
2007 |
| 623 |
LABORATORY SCREENING FOR RHABDOMYOLYSIS AND REFERENCE LABORATORY VALUES OF MUSCULAR ACTIVITY FOR BEGINNERS PRACTICING VIGOROUS EXERCISES |
2007 |
| 624 |
Predictive value of ischemia modified albumin (IMA) in patients with acute coronary syndromes (ACS). |
2007 |
| 625 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |
| 626 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |
| 627 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |
| 628 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |
| 629 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |
| 630 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
2007 |